Risk of depression with GLP-1 receptor agonists use in overweight or obese adults with type 2 diabetes: a new-user, active-comparator cohort study
Insulin signaling impairment in the brain as a risk factor in alzheimers disease
If you're taking GLP-1 medications alongside insulin or sulfonylureas, your doctor may reduce these other medications during titration to reduce the risk of hypoglycaemia
The full chart, the units conversion, per-day and female protocols, and a dose calculator are below
Additionally, ID affects chemokine production and receptor expression, reducing neutrophil chemotaxis and impairing their migration to infection sites (93, 101)
[16] Alcohol consumption may also contribute to increased appetite and reduced inhibition around food choices